CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
0.8223
-0.0277 (-3.26%)
At close: Jan 2, 2026, 4:00 PM EST
0.8240
+0.0017 (0.21%)
After-hours: Jan 2, 2026, 4:10 PM EST
CASI Pharmaceuticals Employees
CASI Pharmaceuticals had 233 employees as of December 31, 2024. The number of employees increased by 57 or 32.39% compared to the previous year.
Employees
233
Change (1Y)
57
Growth (1Y)
32.39%
Revenue / Employee
$115,219
Profits / Employee
-$211,953
Market Cap
16.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 233 | 57 | 32.39% |
| Dec 31, 2023 | 176 | -48 | -21.43% |
| Dec 31, 2022 | 224 | 48 | 27.27% |
| Dec 31, 2021 | 176 | 32 | 22.22% |
| Dec 31, 2020 | 144 | 19 | 15.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CASI News
- 10 days ago - CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements - Accesswire
- 22 days ago - CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing - Accesswire
- 25 days ago - CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting - Accesswire
- 6 weeks ago - CASI Pharmaceuticals Announces Changes in Board Governance - Accesswire
- 7 weeks ago - CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results - Accesswire
- 7 weeks ago - CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ - Accesswire
- 2 months ago - CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference - Accesswire
- 2 months ago - CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting - Accesswire